SCHEMBL6667286

SCHEMBL6667286

O=C(Nc1ccncc1)c1cccs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 1.00
MEN1 O00255 6/20 0.79
KMT2A Q03164 6/20 0.79
NPC1 O15118 6/20 0.79
RAB9A P51151 6/20 0.79
TDP1 Q9NUW8 1/20 0.79
SMN1; SMN2 Q16637 5/20 0.77
HTT P42858 3/20 0.77
GAA P10253 1/20 0.77
LMNA P02545 3/20 0.71
PTBP1 P26599 1/20 0.71
KLF5 Q13887 1/20 0.71
MAPT P10636 2/20 0.68
GFER P55789 1/20 0.68
TP53 P04637 2/20 0.62
CASP3 P42574 1/20 0.62
CASP2 P42575 1/20 0.62
TSHR P16473 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1929165 0.85 NPC1 (0.85) ALDH1A1MEN1KMT2ANPC1RAB9A
Hydrochloric Acid SCHEMBL31228835 0.84 NPC1 (0.82) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL19392293 0.84 NPC1 (0.89) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL8771200 0.84 NPC1 (0.89) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL6669304 0.83 HTT (1.00) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL4964101 0.82 HTT (0.97) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL2063276 0.82 NPC1 (0.86) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL6804148 0.81 NPC1 (0.77) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL22804218 0.81 NPC1 (0.83) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL8770282 0.81 MEN1 (0.85) ALDH1A1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013138341-A1 TOPK INHIBITING COMPOUNDS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2013-09-19 WO disclosed
EP-1453828-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME AstraZeneca AB (SE) 2004-09-08 EP disclosed
WO-2003032897-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME ASTRAZENECA AB (SE) 2003-04-24 WO disclosed